Science & Enterprise subscription

Follow us on Twitter

  • An evaluation of a two year-old home care service for cancer patients shows the program reduces chances of later ho… https://t.co/TupWwuG3ok
    about 18 hours ago
  • New post on Science and Enterprise: Home-Based Cancer Care Boosts Outcomes, Cuts Costs https://t.co/9zcrG432As #Science #Business
    about 18 hours ago
  • Trump: U.S. will terminate relationship with the World Health Organization in wake of Covid-19...… https://t.co/nUXjHixhfe
    about 19 hours ago
  • A company creating a gene therapy for age-related macular degeneration activated with near-infrared rays received a… https://t.co/MOueVM6Nqj
    about 23 hours ago
  • New post on Science and Enterprise: NIH Funds Light-Aided Gene Therapy for Eye Disease https://t.co/CnDzdinH43 #Science #Business
    about 24 hours ago

Please share Science & Enterprise

Antibody Drug Biotech Raises $105M in Venture Funds

Human B-cell

A company that says it has a faster process for discovering therapeutic antibodies is raising $105 million in its second venture finance round. . . . → Read More: Antibody Drug Biotech Raises $105M in Venture Funds

Covid-19 Therapies Designed with Virtual Reality, A.I.

SARS-CoV-2 protease

Two companies are using deep learning and virtual reality to design treatments for Covid-19 infections, attacking a different target than most drugs being developed. . . . → Read More: Covid-19 Therapies Designed with Virtual Reality, A.I.

FDA Analyzing Real-World Evidence on Covid-19

Network pointer

The Food and Drug Administration is analyzing collections of health records to gain more evidence-based insights into the course of the Covid-19 pandemic. . . . → Read More: FDA Analyzing Real-World Evidence on Covid-19

Trial Tests Liquid Biopsy Feasibility in Lung Cancer

Blood sample tubes

Companies that offer biotechnology, diagnostics, and analytics are testing liquid biopsies to make personalized diagnosis and care feasible for lung cancer patients. . . . → Read More: Trial Tests Liquid Biopsy Feasibility in Lung Cancer

FDA Stops Home Covid-19 Diagnostic Test

Covid-19 illustration

The Food and Drug Administration asked designers of a Covid-19 test collecting samples at home for research to stop giving results to individuals. . . . → Read More: FDA Stops Home Covid-19 Diagnostic Test

Mayo Clinic, A.I. Company Study Covid-19 Heart Disease

Heart and major blood vessels

A developer of software to diagnose heart disease from images with artificial intelligence is assessing Covid-19 infection patients for heart ailments with the Mayo Clinic. . . . → Read More: Mayo Clinic, A.I. Company Study Covid-19 Heart Disease

Symptom App, Algorithm Predict Covid-19 Infections

Android phone

Data from millions of smartphone app users in the U.K. and U.S. reporting on Covid-19 symptoms show they could estimate a population’s Covid-19 infections. . . . → Read More: Symptom App, Algorithm Predict Covid-19 Infections

Pharmas License A.I.-Aided Gene Therapies

Retinal gene therapy

A university spin-off company designing synthetic viruses with artificial intelligence to deliver gene therapies is licensing its work for eye and muscle disorders. . . . → Read More: Pharmas License A.I.-Aided Gene Therapies

Microsoft, Biotech Examine Covid-19 Immune Response

T-cells illustration

A study is enrolling home-bound participants to learn more about the response of T-cells in the immune system to SARS-CoV-2 viruses causing Covid-19 infections. . . . → Read More: Microsoft, Biotech Examine Covid-19 Immune Response

A.I.-Aided Method Predicts Glaucoma Progression

DARC retinal scan

Clinical trial results show a technique visualizing cells in the retina and analyzed with an algorithm accurately predicts the progression of glaucoma. . . . → Read More: A.I.-Aided Method Predicts Glaucoma Progression